Genomics, proteomics and molecular biology lead to tremendous advances in all fields of
medical sciences. Among these the finding of biomarkers as non invasive indicators of …

The past few decades are characterized by an explosive evolution of genetics and
molecular cell biology. Advances in chemistry and engineering have enabled increased …

BACKGROUND AND AIMS As conversion from calcineurin inhibitor to sirolimus (SRL), a
mechanistic target of rapamycin inhibitor (mTOR‐I), has been shown to enhance …

Peripheral blood mononuclear cells (PBMCs) represent an accessible tissue source for
gene expression profiling in schizophrenia that could provide insight into the molecular …

Although the management of kidney transplant recipients has greatly improved over recent
decades, the assessment of individual risks remains highly imperfect. Individualized …

Identifying new, effective biomarkers for diseases is proving to be a challenging problem.
We have proposed that antibodies may offer a solution to this problem. The physical features …

Acute graft rejection is an important clinical problem in renal transplantation and an adverse
predictor for long term graft survival. Plasma biomarkers may offer an important option for …

Technological advances in molecular and in silico research have enabled significant
progress towards personalized transplantation medicine. It is now possible to conduct …

Renal transplantation (RT) is the preferred treatment for end-stage renal disease. However,
clinical challenges persist, ie, early detection of graft dysfunction, timely identification of …

Extracellular signal-regulated kinase (ERK) signals play important roles in cell death and
survival. However, the role of ERK in the repair process after injury remains to be defined in …